Switch to: References

Add citations

You must login to add citations.
  1. Ethics of HIV cure research: an unfinished agenda. [REVIEW]Jeremy Sugarman, John A. Sauceda, Brandon Brown, Parya Saberi, Mallory O. Johnson, Laney Henley, Samuel Ndukwe, Hursch Patel, Morénike Giwa Onaiwu, Danielle M. Campbell, David Palm, Orbit Clanton, David Kelly, Jan Kosmyna, Michael Louella, Laurie Sylla, Christopher Roebuck, Nora Jones, Lynda Dee, Jeff Taylor, John Kanazawa & Karine Dubé - 2021 - BMC Medical Ethics 22 (1):1-14.
    BackgroundThe pursuit of a cure for HIV is a high priority for researchers, funding agencies, governments and people living with HIV (PLWH). To date, over 250 biomedical studies worldwide are or have been related to discovering a safe, effective, and scalable HIV cure, most of which are early translational research and experimental medicine. As HIV cure research increases, it is critical to identify and address the ethical challenges posed by this research.MethodsWe conducted a scoping review of the growing HIV cure (...)
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • Reconceptualising risk–benefit analyses: the case of HIV cure research.Robert Steel - 2020 - Journal of Medical Ethics 46 (3):212-219.
    Modern antiretroviral therapies are capable of suppressing HIV in the bloodstream to undetectable levels. Nonetheless, people living with HIV must maintain lifelong adherence to ART to avoid the re-emergence of the infection. So despite the existence and efficacy of ART, there is still substantial interest in development of a cure. But HIV cure trials can be risky, their success is as of yet unlikely, and the medical gain of being cured is limited against a baseline of ART access. The medical (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   5 citations